quofenix
a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin meglumine - fellesskapsmessige infeksjoner - antibakterielle midler for systemisk bruk, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4. 4 og 5. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.
eraquell vet 18.7 mg/ g
virbac - ivermektin - oralpasta - 18.7 mg/ g
equimax vet 18.7 mg / 140.3 mg
virbac - ivermektin / prazikvantel - oralgel - 18.7 mg / 140.3 mg
iverpraz vet 18.7 mg / 140.3 mg
norbrook laboratories (ireland) limited - ivermektin / prazikvantel - oralpasta - 18.7 mg / 140.3 mg
ivomec comp 15.5 mg/ g / 77.5 mg/ g
boehringer ingelheim animal health nordics a/s - ivermektin / prazikvantel - oralpasta - 15.5 mg/ g / 77.5 mg/ g
nematel vet 439 mg/ g
le vet beheer b.v. - pyrantelembonat - oralpasta - 439 mg/ g
indium [111in] dtpa 37 mbq/ ml
curium netherlands b.v. - indium (111in) pentetat - injeksjonsvæske, oppløsning - 37 mbq/ ml
ivomec vet 18.7 mg/ g
boehringer ingelheim animal health nordics - ivermektin - oralpasta - 18.7 mg/ g
alverin 18.7 mg/ g
zoetis finland oy - ivermektin - oralpasta - 18.7 mg/ g